MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,000 | +31.8% | 482 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | -4.3% | 482 | 0.0% | 0.00% | – |
| Q4 2015 | $23,000 | +15.0% | 482 | 0.0% | 0.00% | – |
| Q3 2015 | $20,000 | -28.6% | 482 | +100.0% | 0.00% | – |
| Q2 2015 | $28,000 | -9.7% | 241 | 0.0% | 0.00% | – |
| Q1 2015 | $31,000 | +3.3% | 241 | -19.7% | 0.00% | – |
| Q4 2014 | $30,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
| BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
| Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
| Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
| Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
| Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
| HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
| BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
| Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |